Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Surveillance programs in cirrhotic patients enable the detection of hepatocellular carcinoma
(HCC) at early stages, when the tumor is amenable to curative treatments (60% of cases in …

Hepatocellular carcinoma (HCC) is rapidly becoming one of the most prevalent cancers
worldwide. With a rising rate, it is a prominent source of mortality. Patients with advanced …

We previously suggested that in patients with heptocellular carcinoma (HCC), the
conventional Milan criteria (T1/T2) for orthotopic liver transplantation (OLT) could be …

It would be impossible to summarise all of the significant developments in the surgical
management of hepatocellular carcinoma (HCC), even just over the past year, in a …

Objective Liver transplantation is an optimal radical therapy for selected patients with
hepatocellular carcinoma. The stringent organ allocation system driven by the Milan criteria …

Background: Liberal acceptance criteria are used when offering liver transplantation (LTx)
for treatment of hepatocellular carcinoma (HCC) at our center. This provides a unique …

A major obstacle for orthotopic liver transplantation (OLT) as treatment for hepatocellular
carcinoma (HCC) is tumor growth resulting in dropout from the waiting list for OLT. There is a …

We previously proposed modified staging criteria for predicting acceptable outcome after
orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). These were …